drugset / Trial / NCT04609514
Learn to Quit-HIV Pilot Study
RandomizedParallel-groupOpen-labelTreatment
Summary
The study team will conduct a feasibility, acceptability, and preliminary efficacy trial comparing Learn to Quit-HIV (n=30) to an app based on U.S. Clinical Practice Guidelines only (NCI QuitGuide; n=30) among HIV-positive smokers. Both apps will be integrated with NRT and ongoing HIV clinical care.
Timeline
- Start
- 2021-01-25
- Primary completion
- 2022-06-02
- Completion
- 2022-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Nicotine | Unknown | 21 mg | Topical |